MDS, MPN and Leukemia - Part II
Tracks
Plenary Hall
| Sunday, April 12, 2026 |
| 10:35 AM - 12:25 PM |
Speaker
Dr. Mark Litzow
Professor of Medicine in the Division of Hematology
Mayo Clinic
ALL Diagnosis & Management in 2026: Incorporating New Therapies
10:35 AM - 10:55 AM
Dr. Naseema Gangat
Professor of Medicine and Hematology Consultant
Mayo Clinic
Primary Myelofibrosis: Diagnosis & Management
10:55 AM - 11:15 AM
Dr. Naval Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
AML Management in 2026
11:15 AM - 11:35 AM
Dr. Mark Litzow
Professor of Medicine in the Division of Hematology
Mayo Clinic
Management of PH Positive ALL in 2026
11:15 AM - 11:35 AM
Dr. Naval Daver
Associate Professor, Department of Leukemia
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Management of AML Relapse After Allogeneic HCT
11:35 AM - 11:55 AMSession Chair
Murtadha Al Khabori
Senior Consultant Hematologist
Sultan Qaboos University Hospital
Ahmad Alabdulkarim
Specialist Haematologist
Jaber Al-Ahmad Hospital Haematology Department
Marwan Shaheen
Consultant Adult Hematology and Bone Marrow Transplant
King Faisal Specialist Hospital and Research Centre
